cd7 car gd T cells
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 3, 2020 (NCT04702841)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CD7Immunity, passive
CD7 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04702841 | Early Phase 1 (Phase 1) | Jun 3, 2020 | Anhui Medical University, Government of China, PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Government of China | Government | 1 | 0 | 1 | 2020 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | For profit | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1